IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells

Journal of Hypertension

Volumn 33, Issue 8, 2015, Pages 1658-1665

  Li, Ning ^a   Fu, Yan ^b   Chen, Wei ^a   Hu, Gui Qiu ^a   Zhou, Min ^a   Yu, Shui Xing ^a   Zhang, Xiao Jing ^a   Du, Chong Tao ^a   Yang, Yong Jun ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

DNA; interferon inducible protein 16; preeclampsia; soluble endoglin; soluble fms like tyrosine kinase 1; trophoblasts

Indexed keywords

BETA TUBULIN; CHEMOKINE; ENDOGLIN; INTERFERON INDUCIBLE PROTEIN 16; MESSENGER RNA; POLY(DEOXYADENYLATE DEOXYTHYMIDYLATE); TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; IFI16 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; NUCLEAR PROTEIN; PHOSPHOPROTEIN;

ANTIANGIOGENIC ACTIVITY; ANTIGEN RETRIEVAL; ARTICLE; BODY MASS; CESAREAN SECTION; CONTROLLED STUDY; CYTOTROPHOBLAST; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNATE IMMUNITY; MATERNAL AGE; PLACENTA TISSUE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; TISSUE SECTION; TROPHOBLAST; WESTERN BLOTTING; ADULT; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PLACENTA; PREGNANCY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD; CELLS, CULTURED; FEMALE; HUMANS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PLACENTA; POLY DA-DT; PRE-ECLAMPSIA; PREGNANCY; PROTEIN BIOSYNTHESIS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84941200585     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000605     Document Type: Article

References (48)

1. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326: 845-849
2. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010; 5: 173-192
3. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856-2869
4. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4: 700-708
5. Roberts JM. Endothelial dysfunction in preeclampsia. Seminars in reproductive endocrinology; 1998: Copyright( 1998 by Thieme Medical Publishers, Inc.; 1998. pp. 5-15
6. Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, et al. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci U S A 2013; 110: 11109-11114
7. Chatterjee P, Weaver LE, Doersch KM, Kopriva SE, Chiasson VL, Allen SJ, et al. Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice. PloS One 2012; 7: e41884
8. Perucci LO, Gomes KB, Freitas LG, Godoi LC, Alpoim PN, Pinheiro MB, et al. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PloS One 2014; 9: e97632
9. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Med 2006; 12: 642-649
10. Boij R, Svensson J, Nilsson-Ekdahl K, Sandholm K, Lindahl TL, Palonek E, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reproduct Immunol 2012; 68: 258-270
11. Gysler SM, Mulla MJ, Stuhlman M, Sfakianaki AK, Paidas MJ, Stanwood NL, et al. Vitamin D reverses aPL-induced Inflammation and LMWHinduced sFlt-1 release by human trophoblast. Am J Reproduct Immunol 2015; 73: 242-250
12. Seki H. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia. Acta Obstet Gynecol Scand 2015; 93: 959-964
13. Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 2007; 62: 191-201
14. Saito S, Sakai M, Sasaki Y, Nakashima A, Shiozaki A. Inadequate tolerance induction may induce preeclampsia. J Reproduct Immunol 2007; 76: 30-39
15. Baltajian K, Hecht JL, Wenger JB, Salahuddin S, Verlohren S, Perschel FH, et al. Placental lesions of vascular insufficiency are associated with antiangiogenic state in women with preeclampsia. Hypertens Pregnancy 2014; 33: 427-439
16. Yang Y, Zhang J, Gong Y, Liu X, Bai Y, Xu W, et al. Increased expression of prostasin contributes to early-onset severe preeclampsia through inhibiting trophoblast invasion. J California Perinat Assoc 2015; 35: 16-22
17. Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Investig 2003; 111: 649-658
18. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci 1993; 90: 10705-10709
19. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226: 324-328
20. Barsoum IB, Renaud SJ, Graham CH. Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues. Am J Pathol 2011; 178: 2888-2896
21. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992; 267: 19027-19030
22. Gougos A, St Jacques S, Greaves A, O'Connell PJ, d'Apice AJ, Buhring HJ, et al. Identification of distinct epitopes of endoglin, an RGDcontaining glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 1992; 4: 83-92
23. Kaituu-Lino TJ, Palmer KR, Whitehead CL, Williams E, Lappas M, Tong S. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin. Am J Pathol 2012; 180: 888-894
24. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005
25. Chen Q, Tong M, Wu M, Stone PR, Snowise S, Chamley LW. Calcium supplementation prevents endothelial cell activation: possible relevance to preeclampsia. J Hypertens 2013; 31: 1828-1836
26. Zeybek YG, Günel T, Benian A, Aydinli K, Kaleli S. Clinical evaluations of cell-free fetal DNA quantities in preeclamptic pregnancies. J Obstet Gynaecol Res 2013; 39: 632-640
27. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001; 184: 414-419
28. Miranda ML, Macher HC, Muñoz-Hernández R, Vallejo-Vaz A, Moreno-Luna R, Villar J, et al. Role of circulating cell-freeDNAlevels in patientswith severe preeclampsia and HELLP syndrome. Am J Hypertens 2013; 26: 1377-1380
29. Lo YD, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45: 184-188
30. Zhong XY, Gebhardt S, Hillermann R, Tofa KC, Holzgreve W, Hahn S. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early-and late-onset preeclampsia. Clin Chem 2005; 51: 1730-1733
31. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nature Immunol 2010; 11: 997-1004
32. Li T, Diner BA, Chen J, Cristea IM. Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci U S A 2012; 109: 10558-10563
33. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe 2011; 9: 363-375
34. Raffaella R, Gioia D, De Andrea M, Cappello P, Giovarelli M, Marconi P, et al. The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells. Exp Cell Res 2004; 293: 331-345
35. Mazibrada J, De Andrea M, Ritta M, Borgogna C, Dell'eva R, Pfeffer U, et al. In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. Cancer Lett 2010; 287: 33-43
36. Gugliesi F, Dell'oste V, De Andrea M, Baggetta R, Mondini M, Zannetti C, et al. Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene. J Interf Cytokine Res 2011; 31: 609-618
37. Trapani JA, Browne KA, Dawson MJ, Ramsay RG, Eddy RL, Show TB, et al. A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gammain myeloid cells. Immunogenetics 1992; 36: 369-376
38. Gariglio M, Azzimonti B, Pagano M, Palestro G, De Andrea M, Valente G, et al. Immunohistochemical expression analysis of thehuman interferoninducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J Interf Cytokine Res 2002; 22: 815-821
39. Wei W, Clarke CJ, Somers GR, Cresswell KS, Loveland KA, Trapani JA, et al. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem Cell Biol 2003; 119: 45-54
40. Chu X, Chen W, Li N, Hu XZ, Du CT, Yu SX, et al. Cytosolic doublestranded DNA induces nonnecroptotic programmed cell death in trophoblasts via IFI16. J Infect Dis 2014; 210: 1476-1486
41. Koga K, Izumi G, Mor G, Fujii T, Osuga Y. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications. Am J Reproduct Immunol 2014; 72: 192-205
42. Cardenas I, Mulla MJ, Myrtolli K, Sfakianaki AK, Norwitz ER, Tadesse S, et al. Nod1 activation by bacterial iE-DAP induces maternal-fetal inflammation and preterm labor. J Immunol 2011; 187: 980-986
43. Nakada E, Walley KR, Nakada T, Hu Y, von Dadelszen P, Boyd JH. Tolllike receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells. Placenta 2009; 30: 774-779
44. Holzgreve W, Hahn S. Novel molecular biological approaches for the diagnosis of preeclampsia. Clin Chem 1999; 45: 451-452
45. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in preeclamptic pregnancies. Br J Obstet Gynaecol 1998; 105: 632-640
46. Kertesz Z, Hurst G, Ward M, Willis AC, Caro H, Linton EA, et al. Purification and characterization of a complex from placental syncytiotrophoblast microvillous membranes which inhibits the proliferation of human umbilical vein endothelial cells. Placenta 1999; 20: 71-79
47. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999; 155: 293-301
48. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186: 158-166